Products | November 18, 2010

Anacetrapib

Anacetrapib

Related Content

x-ray, ai,
News | X-Ray
Researchers: FDA-cleared Chest X-ray AI Shows Promise in Missed Lung Cancer Detection  

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
mri, contrast agent, FDA
News | Contrast Agents
GE HealthCare: First Patient Dosed in Trial for Manganese-based MRI Contrast Agent

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
New Clinical Data on Portable MRI System’s Enhanced Stroke Detection Capabilities Published
News | Magnetic Resonance Imaging (MRI)
New Clinical Data Available on Portable MRI System’s Enhanced Stroke Detection Capabilities

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
Nuclidium Receives Patent for Radiodiagnostic Program for PSMA-positive Prostate Cancer
News | PET Imaging
Nuclidium Receives Patent for Radiodiagnostic Program for PSMA-positive Prostate Cancer

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
Study Shows High Diagnostic Value, Superior Patient Experience for Portable MRI System
News | Magnetic Resonance Imaging (MRI)
Study Shows High Diagnostic Value, Superior Patient Experience for Portable MRI System

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Focused Ultrasound Therapy
Researchers Develop New Technique that Uses Ultrasound to Activate Drugs Targeting Pancreatic Cancer

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
Immunis, Inc. has announced that a partnership with Springbok Analytics to implement their MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial, assessing the efficacy of its novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
News | Radiology Business
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and Biology, sheds light on the significant lung damage caused by severe COVID-19.
News | Artificial Intelligence
Study Applying AI to CT Scans Unveils Lung Damage Severity in COVID-19 Patients

June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and ...

Time June 11, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Breast Imaging
Breakthroughs in Breast Cancer: Susan G. Komen(R) Scholars and Studies Highlighted at ASCO 2024

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting
News | Radiopharmaceuticals and Tracers
Shine Technologies Partners with Blue Earth Therapeutics for First Supply of Ilumira from Its New Facility

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now